Cancer News and Research

Latest Cancer News and Research

FDA checks metformin drugs for potentially carcinogenic substance

The FDA is checking metformin medications used to treat diabetes for a potential carcinogen, N-nitrosodimethylamine (NDMA).

11 Dec 2019

Blood test could be a better way of guiding treatment for advanced breast cancer patients

A blood test can help identify rare mutations in advanced breast cancer, which may enable patients to access effective treatments more quickly in the future, Cancer Research UK scientists have found.

11 Dec 2019

Bruker launches Luxendo TruLive3D Imager light-sheet imaging system

At the 2019 joint meeting of the American Society for Cell Biology and European Molecular Biology Organization, Bruker today announced the launch of the Luxendo TruLive3D Imager light-sheet imaging system.

From Bruker Nano Surfaces and Metrology 11 Dec 2019

IONTAS antibody for the treatment of B-Cell ALL receives approval for clinical trials

IONTAS Limited, a leader in the discovery and optimization of fully human antibodies, has been informed that International Biotechnology Center Generium, a leading Russian biopharmaceutical company, focused on developing and commercializing pharmaceutical products for the treatment of orphan diseases and cancer, has received approval from the Russian Health Authorities to initiate clinical trials with its CD3/CD19 bispecific antibody for the treatment of B-Cell Acute Lymphoblastic Leukemia.

From FairJourney Biologics 11 Dec 2019

Online decision aid provides more knowledge about the benefits of genomic sequencing

A decision aid developed to support patients undergoing genomic sequencing can reduce the amount of time patients spend speaking with overburdened genetic counselors while helping them were more knowledgeable about the benefits of sequencing, suggests a study from St. Michael's Hospital.

10 Dec 2019

Clinical trial eligibility criteria may be excessive, needlessly excluding patients

Federal regulations may keep lung cancer patients out of clinical trials simply because these patients are on medications that might affect the electrical system of the heart. Drilling into the details quickly turns up reasons to think these regulations may be preventing a substantial proportion of patients from participating in clinical trials.

10 Dec 2019

Fresh red blood cell transfusions are no more beneficial than older ones to critically ill children

A new study led by the Sainte-Justine University Hospital Centre and the University of Montreal, along with the Washington University School of Medicine in St. Louis, has found that transfusions using fresh red blood cells--cells that have spent seven days or less in storage--are no more beneficial than older red blood cells in reducing the risk of organ failure or death in critically ill children.

10 Dec 2019

AGA publishes clinical guideline for managing patients with gastric intestinal metaplasia

Gastric intestinal metaplasia (GIM), which is linked to non-cardia gastric cancer, is often detected during routine endoscopy, leading to questions about how patient care should be managed.

10 Dec 2019

Study provides most detailed classification of acute myeloid leukemia, myelodysplastic syndrome

Results from a study conducted by St. Jude Children's Research Hospital and the Munich Leukemia Laboratory were presented today as a late-breaking abstract at the American Society of Hematology annual meeting. The study integrates genomic and transcriptomic sequencing to provide the most detailed classification of acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) to date.

10 Dec 2019

Researchers aim to exploit DNA mutations in the treatment of blood and bone marrow cancers

In a clinical trial led by Yale Cancer Center and Smilow Cancer Hospital, researchers aim to exploit DNA mutations in the treatment of two blood and bone marrow cancers, a different tacit than the more traditional approach of blunting or switching off genetic mutations linked to cancer.

10 Dec 2019

Combination regimen shows promising results in preclinical models of triple negative breast cancer

Tumor volume in a preclinical model of triple negative breast cancer (TNBC) was reduced four times more when an experimental polo-like kinase 1 (PLK1) inhibitor was combined with a standard-of-care chemotherapeutic agent than when the agent was used alone.

10 Dec 2019

Study explores cost-effectiveness of transient elastography for detecting liver fibrosis

Non-alcoholic fatty liver diseases (NAFLD) and alcohol-related diseases (ALD) are currently the leading cause of chronic disease, cancer and mortality associated with this organ in developed countries.

10 Dec 2019

Immunotherapy more effective than chemotherapy for children, young adults with relapsed B-ALL

New findings from a clinical trial show that treatment with the immunotherapy drug blinatumomab is superior to standard chemotherapy for children and young adults with high- or intermediate-risk B-cell acute lymphoblastic leukemia that has relapsed.

10 Dec 2019

Study finds that even light alcohol consumption may increase overall cancer risk

A new study suggests that even light-to-moderate alcohol consumption may increase overall cancer risk.

10 Dec 2019

‘Food pharmacies’ in clinics: When the diagnosis is chronic hunger

There’s a new question that anti-hunger advocates want doctors and nurses to ask patients: Do you have enough food?

10 Dec 2019

Risk of specific genetic translocation is higher in patients of African ancestry, shows study

Multiple myeloma is a plasma cell cancer that is more common in patients of African American descent than of European American descent.

10 Dec 2019

Combination therapy is safe and effective for older patients diagnosed with acute lymphoblastic leukemia

A study led by The University of Texas MD Anderson Cancer Center showed that treatment combining lower doses of chemotherapy with the monoclonal antibody inotuzumab ozogamicin (INO), with or without the drug blinatumomab, is safe and effective in patients over 60 years of age who were newly diagnosed with a high-risk form of acute lymphoblastic leukemia (ALL) known as Philadelphia chromosome-negative ALL.

10 Dec 2019

Cancer News and Research

Latest Cancer News and Research

FDA checks metformin drugs for potentially carcinogenic substance

Blood test could be a better way of guiding treatment for advanced breast cancer patients

Bruker launches Luxendo TruLive3D Imager light-sheet imaging system

IONTAS antibody for the treatment of B-Cell ALL receives approval for clinical trials

Online decision aid provides more knowledge about the benefits of genomic sequencing

Clinical trial eligibility criteria may be excessive, needlessly excluding patients

Fresh red blood cell transfusions are no more beneficial than older ones to critically ill children

AGA publishes clinical guideline for managing patients with gastric intestinal metaplasia

Study provides most detailed classification of acute myeloid leukemia, myelodysplastic syndrome

Researchers aim to exploit DNA mutations in the treatment of blood and bone marrow cancers

Combination regimen shows promising results in preclinical models of triple negative breast cancer

Study explores cost-effectiveness of transient elastography for detecting liver fibrosis

Immunotherapy more effective than chemotherapy for children, young adults with relapsed B-ALL

Study finds that even light alcohol consumption may increase overall cancer risk

‘Food pharmacies’ in clinics: When the diagnosis is chronic hunger

Risk of specific genetic translocation is higher in patients of African ancestry, shows study

Combination therapy is safe and effective for older patients diagnosed with acute lymphoblastic leukemia

Rutgers researchers identify small mutations for AML and MDS through deep DNA sequencing

Retrospective review: Proton therapy well tolerated in patients undergoing breast conserving surgery

Common antibiotic appears to boost the effect of radiation on tumor cells

Industry Focus - Oncology (1st Edition) eBook

How the Vutara VXL simplifies single-molecule imaging

How cohesin mechanics and nanotracker tech are redefining DNA research

Todd Bauman and Chris Povich

Cancer News and Research

Latest Cancer News and Research

Industry Focus - Oncology (1st Edition) eBook

How the Vutara VXL simplifies single-molecule imaging

How cohesin mechanics and nanotracker tech are redefining DNA research

Todd Bauman and Chris Povich

Newsletters you may be interested in